cefuroxime has been researched along with Necrotizing Pyelonephritis in 17 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To evaluate that hypothesis, 25 patients with acute pyelonephritis of Gram-negative aetiology were given intravenous cefuroxime 1." | 9.09 | Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report. ( Eoconomou, E; Giamarellou, H; Giamarellou-Bourboulis, EJ; Lelekis, M; Perdios, J; Tsouroulas, P, 1999) |
| "To compare the efficacy, safety and cost of cefuroxime and cephradine in the treatment of acute pyelonephritis in pregnancy." | 9.09 | [Prospective, randomized, comparative study of the efficacy, safety and cost of cefuroxime versus cephradine in acute pyelonephritis during pregnancy]. ( Cona, E; Lobos, L; Martínez, MA; Ovalle, A; Valderrama, O; Villablanca, E; Wolff, M, 2000) |
| " The objectives of this study were to assess the clinical efficacy of intravenous cefuroxime as an empirical antibiotic for the treatment of hospitalized women with acute pyelonephritis (APN) caused by Escherichia coli." | 7.83 | Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. ( Chang, UI; Kim, HW; Wie, SH, 2016) |
| "This study was performed to compare the therapeutic efficacy of cefuroxime with that of cefotaxime as initial antimicrobial therapies in women with complicated nonobstructive acute pyelonephritis (APN) caused by Enterobacteriaceae infections." | 7.81 | Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women. ( Chang, UI; Kim, HW; Wie, SH, 2015) |
| "The pharmacokinetics of cefuroxime was studied in 40 pregnant women with acute pyelonephritis." | 7.67 | [Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis]. ( Akhtamova, ZM; Dorokhov, VV; Khokholov, LE; Voropaeva, SD, 1985) |
| " To evaluate that hypothesis, 25 patients with acute pyelonephritis of Gram-negative aetiology were given intravenous cefuroxime 1." | 5.09 | Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report. ( Eoconomou, E; Giamarellou, H; Giamarellou-Bourboulis, EJ; Lelekis, M; Perdios, J; Tsouroulas, P, 1999) |
| "To compare the efficacy, safety and cost of cefuroxime and cephradine in the treatment of acute pyelonephritis in pregnancy." | 5.09 | [Prospective, randomized, comparative study of the efficacy, safety and cost of cefuroxime versus cephradine in acute pyelonephritis during pregnancy]. ( Cona, E; Lobos, L; Martínez, MA; Ovalle, A; Valderrama, O; Villablanca, E; Wolff, M, 2000) |
| " The objectives of this study were to assess the clinical efficacy of intravenous cefuroxime as an empirical antibiotic for the treatment of hospitalized women with acute pyelonephritis (APN) caused by Escherichia coli." | 3.83 | Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli. ( Chang, UI; Kim, HW; Wie, SH, 2016) |
| "This study was performed to compare the therapeutic efficacy of cefuroxime with that of cefotaxime as initial antimicrobial therapies in women with complicated nonobstructive acute pyelonephritis (APN) caused by Enterobacteriaceae infections." | 3.81 | Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women. ( Chang, UI; Kim, HW; Wie, SH, 2015) |
| "This study examined the clinical effectiveness of parenteral cefuroxime and cefotaxime as empirical antibiotics for treating hospitalized women with uncomplicated acute pyelonephritis (APN)." | 3.81 | Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis. ( Chang, UI; Kim, HW; Wie, SH, 2015) |
| " The sensitivity of clinically significant 96 strains from patients with pyelonephritis and 180 strains from patients with lower respiratory tract infections (pneumonia, COPD) was compared for cefuroxime and cefotaxime or ceftriaxone according NCCLS recommendations during 2000-2001 years." | 3.72 | [Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital]. ( Bogdanov, MB; Chernen'kaia, TV, 2003) |
| "To determine the optimal schemes of rational antibacterial therapy of pyelonephritis gravidarum with ampicillin and cephuroxim, assays of the patient urine and studies on the pharmacokinetics of the drugs were performed." | 3.67 | [Antibacterial therapy of pyelonephritis in pregnant women]. ( Abramova, ZI; Akhtamova, ZM; Voropaeva, SD, 1984) |
| "A short-term course of an intravenous cephalosporin (cefuroxime) was used as therapy in 24 cases of pyelonephritis due to susceptible organisms in 23 pregnant women." | 3.67 | Short-course parenteral antibiotic therapy for pyelonephritis in pregnancy. ( Aldridge, KE; Faro, S; Korndorffer, FA; Pastorek, JG; Plauché, WC, 1984) |
| "The pharmacokinetics of cefuroxime was studied in 40 pregnant women with acute pyelonephritis." | 3.67 | [Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis]. ( Akhtamova, ZM; Dorokhov, VV; Khokholov, LE; Voropaeva, SD, 1985) |
| "Cefuroxime seems to be a better candidate as first line therapy, however no clinical study supports its use." | 1.36 | [Empirical antibiotic therapy for urinary tract infection in children. Analysis of three hundred patients admitted to a general hospital]. ( Lefebvre, C; Lombet, J, 2010) |
| "Nausea and vomiting are common problems of pregnancy." | 1.30 | [Vomiting after the first trimester of pregnancy: an alarming symptom]. ( Blom, VM; Braam, RL; Niekel, RA; Reenalda, PE; Seinen, H, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosch-Nicolau, P | 1 |
| Falcó, V | 1 |
| Viñado, B | 1 |
| Andreu, A | 1 |
| Len, O | 1 |
| Almirante, B | 1 |
| Pigrau, C | 1 |
| Chang, UI | 3 |
| Kim, HW | 3 |
| Wie, SH | 3 |
| Lefebvre, C | 1 |
| Lombet, J | 1 |
| Bogdanov, MB | 1 |
| Chernen'kaia, TV | 1 |
| Voropaeva, SD | 4 |
| Emel'ianova, AI | 2 |
| Ankirskaia, AS | 2 |
| Saakian, SS | 2 |
| Maĭorova, VN | 1 |
| Akhtamova, ZM | 2 |
| Abramova, ZI | 2 |
| Faro, S | 1 |
| Pastorek, JG | 1 |
| Plauché, WC | 1 |
| Korndorffer, FA | 1 |
| Aldridge, KE | 1 |
| Minasova, GS | 1 |
| George, J | 1 |
| Chakravarthy, S | 1 |
| John, GT | 1 |
| Jacob, CK | 1 |
| Braam, RL | 1 |
| Seinen, H | 1 |
| Blom, VM | 1 |
| Reenalda, PE | 1 |
| Niekel, RA | 1 |
| Giamarellou-Bourboulis, EJ | 1 |
| Perdios, J | 1 |
| Lelekis, M | 1 |
| Eoconomou, E | 1 |
| Tsouroulas, P | 1 |
| Giamarellou, H | 1 |
| Ovalle, A | 1 |
| Martínez, MA | 1 |
| Wolff, M | 1 |
| Cona, E | 1 |
| Valderrama, O | 1 |
| Villablanca, E | 1 |
| Lobos, L | 1 |
| Cronberg, S | 1 |
| Banke, S | 1 |
| Bergman, B | 1 |
| Boman, H | 1 |
| Eilard, T | 1 |
| Elbel, E | 1 |
| Hugo-Persson, M | 1 |
| Johansson, E | 1 |
| Kuylenstierna, N | 1 |
| Lanbeck, P | 1 |
| Lindblom, A | 1 |
| Paulsen, O | 1 |
| Schönbeck, C | 1 |
| Walder, M | 1 |
| Wieslander, P | 1 |
| Shekhtman, MM | 1 |
| Akhtamova, EM | 1 |
| Khokholov, LE | 1 |
| Dorokhov, VV | 1 |
1 review available for cefuroxime and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Bilateral emphysematous pyelonephritis responding to nonsurgical management.
Topics: Cefuroxime; Ciprofloxacin; Diabetic Nephropathies; Drug Therapy, Combination; Emphysema; Escherichia | 1995 |
3 trials available for cefuroxime and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report.
Topics: Acute Disease; Aged; Cefuroxime; Cephalosporins; Female; Humans; Lipopolysaccharides; Male; Middle A | 1999 |
[Prospective, randomized, comparative study of the efficacy, safety and cost of cefuroxime versus cephradine in acute pyelonephritis during pregnancy].
Topics: Acute Disease; Analysis of Variance; Cefuroxime; Cephalosporins; Cephradine; Cost-Benefit Analysis; | 2000 |
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftibut | 2001 |
13 other studies available for cefuroxime and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2017 |
Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Community-Acquired Infections; E | 2015 |
Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Community-A | 2015 |
Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Cefuroxime; Community-Acquired Infections; | 2016 |
[Empirical antibiotic therapy for urinary tract infection in children. Analysis of three hundred patients admitted to a general hospital].
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Female; Humans; Infant; Male | 2010 |
[Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital].
Topics: Anti-Bacterial Agents; Bronchitis; Cefotaxime; Ceftriaxone; Cefuroxime; Gram-Negative Bacteria; Hosp | 2003 |
[Comparative clinical efficacy of cephotaxim and cefuroxime against the pathogens of inflammation in obstetrics and gynecology].
Topics: Bacterial Infections; Cefotaxime; Cefuroxime; Cephalosporins; Endometritis; Enterococcus faecalis; E | 1983 |
[Antibacterial therapy of pyelonephritis in pregnant women].
Topics: Ampicillin; Bacteriuria; Cefuroxime; Female; Humans; Kinetics; Microbial Sensitivity Tests; Pregnanc | 1984 |
Short-course parenteral antibiotic therapy for pyelonephritis in pregnancy.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Cephalospor | 1984 |
[Effectiveness of using cefuroxime in the obstetrics and gynecology clinic].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Drug Evaluation; Endometritis; Female; Humans; Lac | 1982 |
[Vomiting after the first trimester of pregnancy: an alarming symptom].
Topics: Abdominal Abscess; Adult; Cefuroxime; Cephalosporins; Crohn Disease; Female; Humans; Intestinal Obst | 1998 |
[Rational therapy of pyelonephritis in pregnant women].
Topics: Adolescent; Adult; Ampicillin; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Female; Humans | 1986 |
[Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis].
Topics: Acute Disease; Adolescent; Adult; Biological Availability; Cefuroxime; Cephalosporins; Female; Half- | 1985 |